We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
-6.18%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$1.12B
AUM Growth
-$33M
Cap. Flow
+$42.2M
Cap. Flow %
3.79%
Top 10 Hldgs %
50.64%
Holding
187
New
28
Increased
108
Reduced
38
Closed
10

Sector Composition

Rank Sector Weight
1 Utilities 1.14%
2 Healthcare 0.85%
3 Consumer Staples 0.73%
4 Communication Services 0.55%
5 Financials 0.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIGI icon
51
Vanguard International Dividend Appreciation ETF
VIGI
$8.88B
$3.07M 0.28%
49,506
+883
+2% +$60.3K
VHT icon
52
Vanguard Health Care ETF
VHT
$18B
$2.71M 0.24%
12,090
+59
+0.5% +$14.1K
VIG icon
53
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.68M 0.24%
19,840
-587
-3% -$87.4K
EAGG icon
54
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.98B
$2.61M 0.23%
56,112
+1,369
+3% +$66.7K
VEU icon
55
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$2.48M 0.22%
55,929
-343
-0.6% -$17K
ESGD icon
56
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
$2.3M 0.21%
41,039
+1,197
+3% +$75K
GLD icon
57
SPDR Gold Trust
GLD
$130B
$2.26M 0.2%
+14,628
New +$2.35M
XLK icon
58
State Street Technology Select Sector SPDR ETF
XLK
$114B
$2.13M 0.19%
+35,884
New +$2.45M
CAH icon
59
Cardinal Health
CAH
$53.5B
$2.06M 0.18%
30,917
-482
-2% -$30.6K
OEF icon
60
iShares S&P 100 ETF
OEF
$20.1B
$1.99M 0.18%
+12,250
New +$2.22M
AOA icon
61
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.17B
$1.93M 0.17%
34,775
+1,385
+4% +$84.2K
GILD icon
62
Gilead Sciences
GILD
$167B
$1.91M 0.17%
30,955
+3,632
+13% +$229K
K
63
DELISTED
Kellanova
K
$1.84M 0.16%
28,112
+1,283
+5% +$88.2K
ABBV icon
64
AbbVie
ABBV
$450B
$1.83M 0.16%
13,637
+1,618
+13% +$232K
CAG icon
65
Conagra Brands
CAG
$6.83B
$1.83M 0.16%
56,090
+7,349
+15% +$252K
DUK icon
66
Duke Energy
DUK
$97.5B
$1.79M 0.16%
19,241
+2,611
+16% +$280K
NRG icon
67
NRG Energy
NRG
$27.2B
$1.77M 0.16%
46,234
+3,736
+9% +$149K
ETR icon
68
Entergy
ETR
$52.8B
$1.75M 0.16%
34,752
+4,456
+15% +$256K
PNW icon
69
Pinnacle West Capital
PNW
$13.1B
$1.74M 0.16%
26,903
+3,626
+16% +$267K
VGT icon
70
Vanguard Information Technology ETF
VGT
$139B
$1.72M 0.15%
44,688
-2,120
-5% -$93.2K
EIX icon
71
Edison International
EIX
$29.9B
$1.71M 0.15%
30,285
+3,971
+15% +$263K
KHC icon
72
Kraft Heinz
KHC
$30.7B
$1.7M 0.15%
50,820
+7,579
+18% +$282K
IQDG icon
73
WisdomTree International Quality Dividend Growth Fund
IQDG
$701M
$1.69M 0.15%
64,175
+11,189
+21% +$332K
CTRA
74
DELISTED
Coterra Energy
CTRA
$1.61M 0.14%
61,766
+6,937
+13% +$199K
IBM icon
75
IBM
IBM
$200B
$1.59M 0.14%
13,404
+1,846
+16% +$242K

Similar funds

Trilogy Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Trilogy Capital held 187 positions worth $1.12B, down 2.9% from $1.15B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Trilogy Capital deployed $42.2M of net new capital in Q3 2022, opening 28 new positions and adding to 108 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 63,331 shares worth $6.49M.

By sector, the portfolio is most concentrated in Utilities at 1.1% of assets, up from 1.1% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $5.44M trimmed.

  • Trilogy Capital's largest Q3 2022 buy was iShares 20+ Year Treasury Bond ETF: 63,331 shares worth $6.49M.
  • Trilogy Capital added most to Vanguard Intermediate-Term Bond ETF in Q3 2022, an estimated $7.17M increase.
  • Trilogy Capital's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.44M.
  • Trilogy Capital fully exited JPMorgan Ultra-Short Income ETF in Q3 2022, selling an estimated $2.31M.
  • Trilogy Capital's ten largest holdings make up 51% of its $1.12B portfolio in Q3 2022.
  • Trilogy Capital opened 28 new positions and closed 10 in Q3 2022.
  • Trilogy Capital's portfolio value fell 2.9% quarter-over-quarter to $1.12B.

Based on Trilogy Capital's 13F filing for Q3 2022, filed 21 Oct 2022.